Literature DB >> 22841833

Oxidative stress and glutathione response in tissue cultures from persons with major depression.

Sara A Gibson1, Željka Korade, Richard C Shelton.   

Abstract

There is evidence that major depressive disorder (MDD) is associated with increased peripheral markers of oxidative stress. To explore oxidation and antioxidant response in MDD, we assayed human dermal fibroblast cultures derived from skin biopsies of age-, race-, and sex-matched individuals in depressed and normal control groups (n = 16 each group), cultured in glucose and galactose conditions, for relative protein carbonylation (a measure of oxidative stress), glutathione reductase (GR) expression, and total glutathione concentration. In control-group fibroblasts, galactose induced a significant increase from the glucose condition in both protein carbonylation and GR. The cells from the MDD group showed total protein carbonylation and GR expression in the glucose condition that was significantly higher than control cells in glucose and equivalent to controls in galactose. There was a small decrease in protein carbonylation in MDD cells from glucose to galactose and no significant change in GR. There was no difference in total glutathione among any of the groups. Increased protein carbonylation and GR expression, cellular responses to oxidative stress induced by galactose in control fibroblasts, are present in fibroblasts derived from MDD patients and are not explainable by reduced GR or total glutathione in the depressed patients. These studies support the role of oxidative stress in the pathophysiology of MDD. Further confirmation of these findings could lead to the development of novel antioxidant approaches for the treatment of depression.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22841833      PMCID: PMC3480727          DOI: 10.1016/j.jpsychires.2012.06.008

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  53 in total

1.  Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Wai Tat Chiu; Olga Demler; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

Review 2.  cAMP-dependent protein kinase and the protein kinase family.

Authors:  S S Taylor; D R Knighton; J Zheng; L F Ten Eyck; J M Sowadski
Journal:  Faraday Discuss       Date:  1992       Impact factor: 4.008

Review 3.  Functional biomarkers of depression: diagnosis, treatment, and pathophysiology.

Authors:  Heath D Schmidt; Richard C Shelton; Ronald S Duman
Journal:  Neuropsychopharmacology       Date:  2011-08-03       Impact factor: 7.853

Review 4.  Free radical pathology and antioxidant defense in schizophrenia: a review.

Authors:  S P Mahadik; S Mukherjee
Journal:  Schizophr Res       Date:  1996-03       Impact factor: 4.939

Review 5.  Metabolism and functions of glutathione in brain.

Authors:  R Dringen
Journal:  Prog Neurobiol       Date:  2000-12       Impact factor: 11.685

6.  Enhanced dephosphorylation of cAMP-dependent protein kinase by oxidation and thiol modification.

Authors:  Kenneth M Humphries; Michael S Deal; Susan S Taylor
Journal:  J Biol Chem       Date:  2004-11-08       Impact factor: 5.157

Review 7.  Oxidative stress markers in bipolar disorder: a meta-analysis.

Authors:  Ana C Andreazza; Marcia Kauer-Sant'anna; Benicio N Frey; David J Bond; Flavio Kapczinski; L Trevor Young; Lakshmi N Yatham
Journal:  J Affect Disord       Date:  2008-06-09       Impact factor: 4.839

8.  Total antioxidant capacity and total oxidant status in patients with major depression: impact of antidepressant treatment.

Authors:  Birgul Elbozan Cumurcu; Huseyin Ozyurt; Ilker Etikan; Suleyman Demir; Rifat Karlidag
Journal:  Psychiatry Clin Neurosci       Date:  2009-08-10       Impact factor: 5.188

9.  Oxidative stress in skin fibroblasts cultures of patients with Huntington's disease.

Authors:  Pilar del Hoyo; Alberto García-Redondo; Fernando de Bustos; José Antonio Molina; Youssef Sayed; Hortensia Alonso-Navarro; Luis Caballero; Joaquín Arenas; Félix Javier Jiménez-Jiménez
Journal:  Neurochem Res       Date:  2006-08-30       Impact factor: 4.414

10.  Elevated 5-HT 2A receptors in postmortem prefrontal cortex in major depression is associated with reduced activity of protein kinase A.

Authors:  R C Shelton; E Sanders-Bush; D H Manier; D A Lewis
Journal:  Neuroscience       Date:  2008-12-03       Impact factor: 3.708

View more
  26 in total

1.  Abnormal Expression of MicroRNAs Induced by Chronic Unpredictable Mild Stress in Rat Hippocampal Tissues.

Authors:  Min Zhou; Maohua Wang; Xiaobin Wang; Kezhi Liu; YunQiang Wan; Mao Li; Li Liu; Chunxiang Zhang
Journal:  Mol Neurobiol       Date:  2017-01-12       Impact factor: 5.590

Review 2.  The glutathione system: a new drug target in neuroimmune disorders.

Authors:  Gerwyn Morris; George Anderson; Olivia Dean; Michael Berk; Piotr Galecki; Marta Martin-Subero; Michael Maes
Journal:  Mol Neurobiol       Date:  2014-04-22       Impact factor: 5.590

3.  Unpredictable Chronic Mild Stress Paradigm Established Effects of Pro- and Anti-inflammatory Cytokine on Neurodegeneration-Linked Depressive States in Hamsters with Brain Endothelial Damages.

Authors:  Ennio Avolio; Gilda Fazzari; Maria Mele; Raffaella Alò; Merylin Zizza; Wei Jiao; Anna Di Vito; Tullio Barni; Maurizio Mandalà; Marcello Canonaco
Journal:  Mol Neurobiol       Date:  2016-10-11       Impact factor: 5.590

4.  Morus nigra and its major phenolic, syringic acid, have antidepressant-like and neuroprotective effects in mice.

Authors:  Ana Paula Dalmagro; Anderson Camargo; Ana Lúcia Bertarello Zeni
Journal:  Metab Brain Dis       Date:  2017-08-18       Impact factor: 3.584

Review 5.  Human dermal fibroblasts in psychiatry research.

Authors:  S Kálmán; K A Garbett; Z Janka; K Mirnics
Journal:  Neuroscience       Date:  2016-02-09       Impact factor: 3.590

6.  Melatonin prevents sleep deprivation-associated anxiety-like behavior in rats: role of oxidative stress and balance between GABAergic and glutamatergic transmission.

Authors:  Lei Zhang; Hong-Liang Guo; Hu-Qin Zhang; Tian-Qi Xu; Bing He; Zhen-Hai Wang; Yi-Peng Yang; Xiao-Dan Tang; Peng Zhang; Fang-E Liu
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

7.  Depression, anxiety-like behavior and memory impairment are associated with increased oxidative stress and inflammation in a rat model of social stress.

Authors:  Gaurav Patki; Naimesh Solanki; Fatin Atrooz; Farida Allam; Samina Salim
Journal:  Brain Res       Date:  2013-10-03       Impact factor: 3.252

8.  Impact of depressive symptoms on oxidative stress in patients with psoriasis.

Authors:  Fatih Karababa; Yavuz Yesilova; Enver Turan; Salih Selek; Hacer Altun; Sahabettin Selek
Journal:  Redox Rep       Date:  2013       Impact factor: 4.412

9.  Dysregulated relationship of inflammation and oxidative stress in major depression.

Authors:  B J Rawdin; S H Mellon; F S Dhabhar; E S Epel; E Puterman; Y Su; H M Burke; V I Reus; R Rosser; S P Hamilton; J C Nelson; O M Wolkowitz
Journal:  Brain Behav Immun       Date:  2012-11-29       Impact factor: 7.217

10.  Coordinated messenger RNA/microRNA changes in fibroblasts of patients with major depression.

Authors:  Krassimira A Garbett; Andrea Vereczkei; Sára Kálmán; Jacquelyn A Brown; Warren D Taylor; Gábor Faludi; Željka Korade; Richard C Shelton; Károly Mirnics
Journal:  Biol Psychiatry       Date:  2014-06-02       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.